Evelo Biosciences, Inc. Services Agreements
2 Contracts & Agreements
- Amendment No. 1 to Clinical Master Services Agreement between Evelo Biosciences, Inc. and Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, dated February 8, 2022 (Filed With SEC on March 24, 2022)
- Master Services Agreement, dated September 1, 2018, between Evelo Biosciences, Inc. and Weatherden Ltd (Filed With SEC on February 15, 2019)